Simultaneous Modulated Accelerated Boost Versus Standard Dose Radiotherapy in Esophageal Cancer

NCT02556762 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

202

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Cancer

Interventions

RADIATION: Radiotherapy with simultaneous modulated accelerated boost
RADIATION: Standard dose radiotherapy
DRUG: PF

Sponsor

Chuangzhen Chen